Related Experiment Video
Updated: Aug 5, 2026

07:05
Use of Human Perivascular Stem Cells for Bone Regeneration
Published on: May 25, 2012
Interventional Procedures in Musculoskeletal Regenerative Medicine
Elena Drakonaki1, Gaurav Kant Sharma2, Domenico Romeo3
1Department of Anatomy, School of Medicine University of Crete, Voutes, POBox 2203, Heraklion, 71003, Greece; Diagnostic and Interventional Ultrasound Institution, Heraklion Crete, Greece.
Radiologic Clinics of North America
|August 3, 2026
Summary
Regenerative medicine offers new treatments for musculoskeletal issues, but clinical evidence varies widely. This review critically examines therapies like viscosupplementation, prolotherapy, and stem cells for various conditions.
Area of Science:
- Regenerative medicine
- Musculoskeletal disorder treatment
- Tissue repair and inflammation modulation
Background:
- Regenerative techniques are advancing for musculoskeletal disorders, utilizing natural repair mechanisms and bioactive molecules.
- Clinical evidence for these therapies is inconsistent due to variations in methods, patient selection, and study design.
- Existing research faces challenges including bias, small sample sizes, and limited follow-up durations.
Purpose of the Study:
- To provide a critical overview of current regenerative therapies for musculoskeletal conditions.
- To evaluate the clinical evidence for viscosupplementation, prolotherapy, platelet-rich plasma, collagen, stem cell, and bone marrow aspirate concentrate therapies.
- To discuss the application of these therapies in conditions such as osteoarthritis, chronic low back pain, and various tissue lesions.
Main Methods:
- Literature review and critical analysis of existing studies on regenerative therapies.
- Comparative overview of different regenerative treatment modalities.
- Synthesis of evidence regarding efficacy and limitations for specific musculoskeletal conditions.
Main Results:
- The clinical utility of regenerative therapies is highly variable and requires further rigorous investigation.
- Heterogeneity in protocols, patient selection, and study quality limits definitive conclusions.
- Specific challenges exist for each therapy, including cell source variability and risk of bias.
Conclusions:
- While promising, regenerative therapies require standardized protocols and high-quality clinical trials for validation.
- Further research is needed to overcome limitations in evidence and optimize patient outcomes.
- A critical approach is essential when considering these advanced interventional treatments.
